Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun;8(2):227-234.
doi: 10.1007/s40123-019-0176-8. Epub 2019 Mar 15.

Ocular Manifestations of Granulomatosis with Polyangiitis: A Review of the Literature

Affiliations
Review

Ocular Manifestations of Granulomatosis with Polyangiitis: A Review of the Literature

Evdokia Sfiniadaki et al. Ophthalmol Ther. 2019 Jun.

Abstract

Granulomatosis with polyangiitis (GPA) is a rare systemic autoimmune disease of unknown etiology that is characterized by granulomatous inflammation, tissue necrosis, and vasculitis in small- and medium-sized vessels. Ocular and orbital manifestations are common in almost half of patients with GPA, affecting every structure of the eye, from the eyelid and orbit to the retina, the choroid, and the optic nerve, with a wide range of severity. Since imaging findings are not always specific for the diagnosis of GPA, biopsy is useful to confirm the diagnosis. Regarding treatment, a localized pharmaceutical and surgical approach may be helpful to achieve remission, while immunosuppressive therapy, corticosteroids, and cyclosporine are also useful. In any case, multidisciplinary intervention is required to reduce the rates of relapse and morbidity in patients with GPA.

Keywords: Diagnosis; Eye; Ocular; Orbital; Treatment; Wegener’s.

PubMed Disclaimer

References

    1. Catanoso M, Macchioni P, Boiardi L, et al. Epidemiology of granulomatosis with polyangiitis (Wegener’s granulomatosis) in Northern Italy: a 15-year population-based study. Semin Arthritis Rheum. 2014;44(2):202–207. doi: 10.1016/j.semarthrit.2014.05.005. - DOI - PubMed
    1. Greco A, Marinelli C, Fusconi M, et al. Clinic manifestations in granulomatosis with polyangiitis. Int J Immunopathol Pharmacol. 2016;29(2):151–159. doi: 10.1177/0394632015617063. - DOI - PMC - PubMed
    1. Comarmond C, Cacoub P. Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment. Autoimmun Rev. 2014;13(11):1121–1125. doi: 10.1016/j.autrev.2014.08.017. - DOI - PubMed
    1. Tarabishy AB, Schulte M, Papaliodis GN, Hoffman GS. Wegener’s granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Surv Ophthalmol. 2010;55(5):429–444. doi: 10.1016/j.survophthal.2009.12.003. - DOI - PubMed
    1. Csernok E, Gross WL. Current understanding of the pathogenesis of granulomatosis with polyangiitis (Wegener’s) Expert Rev Clin Immunol. 2013;9(7):641–648. doi: 10.1586/1744666X.2013.811052. - DOI - PubMed

LinkOut - more resources